School News

Gil I. Wolfe, MD, UB Distinguished Professor and the Irvin and Rosemary Smith Chair of the Department of Neurology, is involved in trials of FcRn (neonatal FC receptor) antagonists that offers a new approach to treating myasthenia gravis (MG).

A promising alternative to opioids being developed in the Buffalo and Rochester regions is one step closer to meeting a critical need in pain management, thanks to a pivotal business partnership and exclusive licensing agreements with the University at Buffalo.

Steven J. Fliesler, PhD, has been named the 2022 recipient of the Retina Research Foundation’s (RRF) Paul Kayser International Award in Retina Research presented by the International Society for Eye Research (ISER).

For teens who have struggled with obesity, it probably sounded too good to be true: a weekly injection that could help them control their eating and lead to weight loss. But the results of the clinical trial on the drug semaglutide, released earlier this month in the New England Journal of Medicine and presented at the discipline’s major conference, Obesity Week, turned out to be better than anything the participants — or even the researchers — expected.

The request by children’s hospitals nationwide this month that the federal government declare a formal state of emergency given the surge in respiratory syncytial virus (RSV) and flu cases was no surprise to Oscar G. Gómez, MD, PhD, associate professor of pediatrics.

Three members of the Jacobs School of Medicine and Biomedical Sciences faculty have been honored with SUNY Diversity in Medicine Mentoring Awards.

Thaddeus P. Waters, MD, has been installed as the inaugural Amol S. Lele, MD, Professor and Chief of the Division of Maternal-Fetal Medicine in the Department of Obstetrics and Gynecology at the Jacobs School of Medicine and Biomedical Sciences.

Kathleen E. Bethin, MD, PhD, clinical professor of pediatrics and her research team have been lauded by the Pediatric Diabetes Consortium (PDC) for their contributions to the PIONEER TEENS clinical trial sponsored by the Danish pharmaceutical company Novo Nordisk.

We are excited to welcome a new faculty member to our department — Kedar Aras, PhD.

Viewing intentional violence as a public health issue has led Robert Gore, MD ’02, down an interesting path, both personally and professionally.

The Jacobs School of Medicine and Biomedical Sciences researchers who have changed the way concussions are treated have been awarded $4.8 million from the U.S. Department of Defense (DOD) to conduct a clinical trial to evaluate whether incorporating elements from the Buffalo Concussion Protocol to the DOD’s current concussion protocol would improve outcomes for active members of the military who sustain a concussion.

A Jacobs School of Medicine and Biomedical Sciences researcher has been awarded a National Heart, Lung and Blood Institute grant to explore how changes in arterial stiffness elicit vascular smooth muscle cell (VSMC) behaviors that contribute to cardiovascular disease.

A team of Jacobs School of Medicine and Biomedical Sciences researchers has published a paper that provides novel guidelines for clinicians when discussing brain atrophy with their multiple sclerosis (MS) patients.